Replays of
Money Info Investing News Show
Where To Invest Information
March 2017 – April 2017 and May 2017
Show Replays
Watch Money Info
Investment News Show Replays
June 6, 2017 Show:
The June 6, 2017 Money Info Investing News Show features live interview with
Terry Howlett, President & Chief Executive Officer
Skinvisible, Inc.
(Stock Symbol: SKVI)
SKINVISIBLE PHARMACEUTICALS, INC.
See Corporate site: Skinvisible.com
Get SKVI Stock Quote
See Latest Company News
Hear a replay of the interview:
The Show Also Features
Texas Oil and Gas Investing News
Live Interview with Tim Connolly, CEO of Corporate Strategies, LLC
For over 30 years, Corporate Strategies has created successful outcomes out of business issues and opportunities for a broad portfolio of companies and clients.
These include law firms, banks, oil & gas producers, hedge funds, insurance companies and numerous investor groups including capital providers of both public and private equity.
See More at Corporate Strategies Website: Corporate-Strategies.net
Tim discusses undervalued oil & gas stocks and where to invest now in the oil & gas sector.
Hear Part 1 of the show:
SKINVISIBLE PHARMACEUTICALS, INC.
See Corporate site: Skinvisible.com
Terry Howlett, President & Chief Executive Officer Skinvisible, Inc. discusses the recent news announcement:
Skinvisible Completes First Sale of DermSafe Hand Sanitizer in China
Germ Protection Now Available to Millions of People in China
Skinvisible Pharmaceuticals, Inc. (SKVI), developer of over 40 topical prescriptions, over-the-counter and cosmeceutical products using its patented Invisicare® polymer delivery systems, is pleased to announce it has completed its first international sale of DermSafe® hand sanitizer through its agent InterSpace Global, Inc. (“InterSpace”). InterSpace is an exporter of “made in USA” products with offices in Salt Lake City, Utah and Shenzhen, China. InterSpace has completed its first sale of DermSafe® with a direct sales company in Shanghai, China.
“We were very excited to be invited to the official launch event of DermSafe in Shanghai this past week, where we shared the benefits of DermSafe to the over 1,200 enthusiastic direct sales agents in attendance,” said Terry Howlett, President of Skinvisible. “This first order of 10,000 units is just the beginning for this company that is gearing up for an even larger introductory event next month. China, with a population of over 1.4 billion people, is one of the fastest growing economies in the world and represents a huge market for Skinvisible products, not only for our DermSafe hand sanitizer but also our OTC line of products including our anti-aging skincare line.”
Skinvisible has developed skin care products using its patented Invisicare polymer delivery systems and transdermal cannabis products from hemp-derived CBD, with its new developments to include cannabinoids from marijuana CBD and THC.
Skinvisible Brings Patented Technology to the Topical and Transdermal Cannabis Industry
Invisicare Delivery System to Enhance Medical and Recreational Marijuana Product Lines
Skinvisible Pharmaceuticals, Inc., developers of over 40 topical prescription (Rx), over-the-counter (OTC) and cosmeceutical products using its patented Invisicare® polymer delivery systems, announces it has now additionally developed topical and transdermal cannabis products from hemp-derived CBD; with its next developments to include cannabinoids from marijuana (CBD and THC).
See News Report
The cannabis market that Skinvisible has entered is vast and one of the fastest growing markets. There is a growing positive public opinion regarding the cannabis industry due to the increasing amount of encouraging scientific research proving the benefits and the increasingly supportive cannabis laws. The legal marijuana industry (medical and recreational) in the USA has reached over $6 billion in annual sales and is expected to increase to over $20 billion by 2020. In Canada, where the entire country is primed to add recreational marijuana nationally this year, the market is projected to reach $2.5 billion, with some future estimates at a staggering $10 to $22 billion annually. Skinvisible is poised to be a part of this expanding market. It is part of the ancillary cannabis market as Skinvisible does not sell or touch cannabis; it sells its proprietary Invisicare polymers coupled with proven product formulations and services to its licensees. Skinvisible will help bring science-based, patent protected products into this emerging industry.
Skinvisible’s Invisicare drug delivery technology enhances how ingredients are delivered to the skin and through the skin. Protected by comprehensive patents, Invisicare is the integral component of every formula developed by Skinvisible, including its cannabis product line. The Invisicare patents protect all Skinvisible formulations from duplication in the marketplace.
Skinvisible, Inc., through its wholly owned subsidiary, Skinvisible Pharmaceuticals, Inc., is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products to treat acne, skin cancers, eczema, fungal infections, inflammation, warts and dermatitis along with sunscreens, anti-aging products, alcohol-free hand sanitizing lotions, pre-surgical preparations, and various other medical treatments using its patented technology Invisicare®.
Skinvisible’s primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products.
CLICK HERE TO SEE CURRENT LICENSEES.
The Technology: Invisicare® is a patented technology that enhances how drugs are delivered on, in or through the skin. It can control the release of active ingredients, providing a greater and longer release, while at the same time reducing irritation to the skin. It also binds products to the skin for 4 hours and more, resisting wash-off and rub-off. Skinvisible has developed a portfolio of 40+ topical products using Invisicare (prescription, over-the-counter and cosmeceutical) and also works directly with companies to enhance their products, especially ones coming off patent. Invisicare can be tailored to almost any type of molecule and the needs our customers. Learn more at WWW.INVISICARE.COM.
News
May 23, 2017 Show:
Undervalued Medical Products Stock Featured on Money Info Investment News
The May 23, 2017 where to invest now Money Info Investing News Show features a live interview with
Eric Bauer, COO of RMS Medical Systems, Inc.
(Stock Symbol: REPR)
Hear a replay of the interview:
Part 1 of the show features where to invest now market strategies discussion with Greg Wyatt, Gary Cella and Charles Moskowitz.
Hear a replay of Part 1 of the show:
Visit the corporate website: RMSMedicalProducts.com
Click Here For REPR stock quotes,
trading charts and latest news releases
See RMS Medical Investors Information Page with financials
Eric Bauer, COO of RMS Medical Systems, Inc. (Stock Symbol: REPR) discusses attendance at a major medical products company trade show and new mobile phone apps to enhance the performance of RMS Medical Products.
Visit the corporate website: RMSMedicalProducts.com
Click Here For REPR stock quotes,
trading charts and latest news releases
See RMS Medical Investors Information Page with financials
RMS Medical Products
Inspiration for health, freedom for living
RMS Medical Products MISSION:
To improve the Quality of Life of patients around the world
through the design, development and delivery of the
highest quality innovative therapeutic solutions.
Worldwide, RMS Medical Products drives healthcare inspiration – in the minds of our patients, our employees, our customers and our shareholders – to give everyone greater freedom for living. We design and manufacture safe, affordable medical devices to make quality healthcare a reality for everyone.
We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers, and careful consideration for the patient experience. Our primary products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™ and RES-Q-VAC®Hand Held Medical Suction.
We are passionate about helping people with our reliable medical devices made at our HQ in Chester, NY (USA). Our products, as well as product support, are offered worldwide by RMS and through a global network of distributors and service providers.
Eric Bauer has over 35 years of varied manufacturing experience. Mr. Bauer started his career as a Manufacturing Engineer and has held positions in operations, sales, marketing, finance and general management. He was President of a company which manufactured micro-pumps for both the cosmetic and pharmaceutical industries, with operations being both ISO and FDA certified.
Mr. Bauer was also CEO of a leading developer and manufacturer of prestige cosmetics and body care products. Mr. Bauer led a cultural transformation from a family owned business to a world-class, quality and process driven manufacturer, resulting in significant sales growth.
Mr. Bauer has a degree in Engineering from SUNY at Buffalo, an MBA from the University of Rochester and has attended executive development programs at MIT, Columbia and Duke Universities.
The Freedom60 has a proprietary technology
that makes it desirable for the
delivery of medications in a wide variety of therapies.
It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.
Medical Stock News
RMS announces hiring of Eric Bauer as Chief Operating Officer
Mr. Bauer brings to RMS over 25 years of experience driving operational excellence in growing organizations within FDA regulated environments. – See News
May 16, 2017 Part 1:
Where To Invest In Small Cap Stocks Undervalued Medical Products Small Cap Stocks on Investing News Show
The May 16, 2017 Money Info Investing News Show features undervalued medical products stocks and live interview with
Ric Schumacher, President of
Pressure Biosciences, Inc.
(Stock Symbol: PBIO)
Watch a replay of the interview:
See corporate site: PressureBiosciences.com
Get PBIO Stock Quote
See Latest Company Press Releases
Lab Instruments Medical Products Stock
Pressure BioSciences, Inc. (OTCQB: PBIO) is a life sciences tools company focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on our game-changing Pressure Cycling Technology (“PCT”).
PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels (up to 90,000 psi) to safely, conveniently and reproducibly control the actions of molecules in biological samples, e.g., the rupture (lysis) of cells and tissues from human, animal, plant, and microbial sources, and the inactivation of pathogens.
See Pressure BioSciences Life Sciences Lab Instruments Products Page
Pressure BioSciences, Inc. (“PBI”) (PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions.
To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. Customers also use PBIO products in other areas, such as bio-therapeutics characterization, soil & plant biology, vaccine development, and counter-bioterror applications.
May 16, 2017 Show Part 2
Healthy Food Small Cap Stocks on Investment News Show
The May 16, 2017 Money Info Investing News Show features a live interview with
Sean Folkson
President, Chief Executive Officer and Director
NightFood Holdings, Inc. (Stock Symbol: NGTF)
Hear a replay of the interview:
See Corporate site: NightFood.com
Get NGTF Stock Quote
See Company Facebook Page
A “Better-for-you” snack company
“The problem we’re solving is very relatable. That makes it interesting to an audience, and, therefore, very attractive to the media outlets themselves,” commented NightFood CEO Sean Folkson.
NightFood (OTCQB: NGTF), “The Nighttime Snack Company”, is a snack food company dedicated to providing consumers delicious, better-for-you choices for evening snacking.
NightFood is the first company to create products to address the unique nutritional needs consumers have at night. 44% of snack consumption occurs at night, representing a consumer spend of over $1B weekly on nighttime snacks.
NightFood creates, manufactures, and distributes products to help consumers satisfy nighttime cravings in a better, healthier, more sleep friendly way.
For more information, visit http://ir.nightfood.com and NightFood.com
May 2, 2017 Show:
Transdermal Cannabis Products Stock on Investment News Show
The May 2, 2017 Money Info Investing News Show features live interview with
Terry Howlett, President & Chief Executive Officer
Skinvisible, Inc.
(Stock Symbol: SKVI)
SKINVISIBLE PHARMACEUTICALS, INC.
See Corporate site: Skinvisible.com
Get SKVI Stock Quote
See Latest Company News
Hear a replay of the interview:
Hear Part 1 of the show:
They have developed skin care products using its patented Invisicare polymer delivery systems and transdermal cannabis products from hemp-derived CBD, with its new developments to include cannabinoids from marijuana CBD and THC.
Skinvisible Brings Patented Technology to the Topical and Transdermal Cannabis Industry
Invisicare Delivery System to Enhance Medical and Recreational Marijuana Product Lines
Skinvisible Pharmaceuticals, Inc., developers of over 40 topical prescription (Rx), over-the-counter (OTC) and cosmeceutical products using its patented Invisicare® polymer delivery systems, announces it has now additionally developed topical and transdermal cannabis products from hemp-derived CBD; with its next developments to include cannabinoids from marijuana (CBD and THC).
See News Report
The cannabis market that Skinvisible has entered is vast and one of the fastest growing markets. There is a growing positive public opinion regarding the cannabis industry due to the increasing amount of encouraging scientific research proving the benefits and the increasingly supportive cannabis laws. The legal marijuana industry (medical and recreational) in the USA has reached over $6 billion in annual sales and is expected to increase to over $20 billion by 2020. In Canada, where the entire country is primed to add recreational marijuana nationally this year, the market is projected to reach $2.5 billion, with some future estimates at a staggering $10 to $22 billion annually. Skinvisible is poised to be a part of this expanding market. It is part of the ancillary cannabis market as Skinvisible does not sell or touch cannabis; it sells its proprietary Invisicare polymers coupled with proven product formulations and services to its licensees. Skinvisible will help bring science-based, patent protected products into this emerging industry.
Skinvisible’s Invisicare drug delivery technology enhances how ingredients are delivered to the skin and through the skin. Protected by comprehensive patents, Invisicare is the integral component of every formula developed by Skinvisible, including its cannabis product line. The Invisicare patents protect all Skinvisible formulations from duplication in the marketplace.
Skinvisible, Inc., through its wholly owned subsidiary, Skinvisible Pharmaceuticals, Inc., is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products to treat acne, skin cancers, eczema, fungal infections, inflammation, warts and dermatitis along with sunscreens, anti-aging products, alcohol-free hand sanitizing lotions, pre-surgical preparations, and various other medical treatments using its patented technology Invisicare®.
Skinvisible’s primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products.
CLICK HERE TO SEE CURRENT LICENSEES.
The Technology: Invisicare® is a patented technology that enhances how drugs are delivered on, in or through the skin. It can control the release of active ingredients, providing a greater and longer release, while at the same time reducing irritation to the skin. It also binds products to the skin for 4 hours and more, resisting wash-off and rub-off. Skinvisible has developed a portfolio of 40+ topical products using Invisicare (prescription, over-the-counter and cosmeceutical) and also works directly with companies to enhance their products, especially ones coming off patent. Invisicare can be tailored to almost any type of molecule and the needs our customers. Learn more at WWW.INVISICARE.COM.
News
April 25, 2017 Show
The show features a live interview with
Eric Bauer, COO of RMS Medical Systems, Inc.
(Stock Symbol: REPR)
Hear a replay of The interview:
Hear a replay of Part 1 of the Show:
Visit the corporate website: RMSMedicalProducts.com
Click Here For REPR stock quotes,
trading charts and latest news releases
See RMS Medical Investors Information Page with financials
The Show Also Features
Texas Oil and Gas Investing News
Live Interview with Tim Connolly, CEO of Corporate Strategies, LLC
For over 30 years, Corporate Strategies has created successful outcomes out of business issues and opportunities for a broad portfolio of companies and clients.
These include law firms, banks, oil & gas producers, hedge funds, insurance companies and numerous investor groups including capital providers of both public and private equity.
See More at Corporate Strategies Website: Corporate-Strategies.net
Tim discusses undervalued oil & gas stocks and where to invest now in the oil & gas sector.
RMS Medical Products
Inspiration for health, freedom for living
RMS Medical Products MISSION:
To improve the Quality of Life of patients around the world
through the design, development and delivery of the
highest quality innovative therapeutic solutions.
Worldwide, RMS Medical Products drives healthcare inspiration – in the minds of our patients, our employees, our customers and our shareholders – to give everyone greater freedom for living. We design and manufacture safe, affordable medical devices to make quality healthcare a reality for everyone.
We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers, and careful consideration for the patient experience. Our primary products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™ and RES-Q-VAC®Hand Held Medical Suction.
We are passionate about helping people with our reliable medical devices made at our HQ in Chester, NY (USA). Our products, as well as product support, are offered worldwide by RMS and through a global network of distributors and service providers.
Eric Bauer has over 35 years of varied manufacturing experience. Mr. Bauer started his career as a Manufacturing Engineer and has held positions in operations, sales, marketing, finance and general management. He was President of a company which manufactured micro-pumps for both the cosmetic and pharmaceutical industries, with operations being both ISO and FDA certified.
Mr. Bauer was also CEO of a leading developer and manufacturer of prestige cosmetics and body care products. Mr. Bauer led a cultural transformation from a family owned business to a world-class, quality and process driven manufacturer, resulting in significant sales growth.
Mr. Bauer has a degree in Engineering from SUNY at Buffalo, an MBA from the University of Rochester and has attended executive development programs at MIT, Columbia and Duke Universities.
The Freedom60 has a proprietary technology
that makes it desirable for the
delivery of medications in a wide variety of therapies.
It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.
Medical Stock News
RMS announces hiring of Eric Bauer as Chief Operating Officer
Mr. Bauer brings to RMS over 25 years of experience driving operational excellence in growing organizations within FDA regulated environments. – See News
Medical Products Stock News
Where To Invest Undervalued Stocks
April 11, 2017 Show:
Undervalued Medical Products Stock
On Money Info Investment News Show
The April 11, 2017 show features a live interview with
Eric Bauer, COO of RMS Medical Systems, Inc.
(Stock Symbol: REPR)
Hear a replay of Part 1 of the Show:
Hear a Replay of the Eric Bauer RMS Medical Systems, Inc. interview:
Visit the corporate website: RMSMedicalProducts.com
Click Here For REPR stock quotes,
trading charts and latest news releases
See RMS Medical Investors Information Page with financials
RMS Medical Products – inspiration for health, freedom for living
RMS Medical Products MISSION:
To improve the Quality of Life of patients around the world
through the design, development and delivery of the
highest quality innovative therapeutic solutions.
Worldwide, RMS Medical Products drives healthcare inspiration – in the minds of our patients, our employees, our customers and our shareholders – to give everyone greater freedom for living. We design and manufacture safe, affordable medical devices to make quality healthcare a reality for everyone.
We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers, and careful consideration for the patient experience. Our primary products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™ and RES-Q-VAC®Hand Held Medical Suction.
We are passionate about helping people with our reliable medical devices made at our HQ in Chester, NY (USA). Our products, as well as product support, are offered worldwide by RMS and through a global network of distributors and service providers.
Eric Bauer, COO
Eric Bauer has over 35 years of varied manufacturing experience. Mr. Bauer started his career as a Manufacturing Engineer and has held positions in operations, sales, marketing, finance and general management. He was President of a company which manufactured micro-pumps for both the cosmetic and pharmaceutical industries, with operations being both ISO and FDA certified.
Mr. Bauer was also CEO of a leading developer and manufacturer of prestige cosmetics and body care products. Mr. Bauer led a cultural transformation from a family owned business to a world-class, quality and process driven manufacturer, resulting in significant sales growth.
Mr. Bauer has a degree in Engineering from SUNY at Buffalo, an MBA from the University of Rochester and has attended executive development programs at MIT, Columbia and Duke Universities.
The Freedom60 has a proprietary technology
that makes it desirable for the
delivery of medications in a wide variety of therapies.
It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.
Medical Stock News
RMS announces hiring of Eric Bauer as Chief Operating Officer
Mr. Bauer brings to RMS over 25 years of experience driving operational excellence in growing organizations within FDA regulated environments. – See News
March 28, 2017
The March 28th Money Info Investing News Show features
undervalued medical products stocks and live interview with CEOs.
Terry Howlett, President & Chief Executive Officer
Skinvisible, Inc.
(Stock Symbol: SKVI)
and
Ric Schumacher, President of
Pressure Biosciences, Inc.
(Stock Symbol: PBIO)
See corporate site: PressureBiosciences.com
Get PBIO Stock Quote
See Latest Company Press Releases
SKINVISIBLE PHARMACEUTICALS, INC.
See Corporate site: Skinvisible.com
Get SKVI Stock Quote
See Latest Company News
Skinvisible, Inc., through its wholly owned subsidiary, Skinvisible Pharmaceuticals, Inc., is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products to treat acne, skin cancers, eczema, fungal infections, inflammation, warts and dermatitis along with sunscreens, anti-aging products, alcohol-free hand sanitizing lotions, pre-surgical preparations, and various other medical treatments using its patented technology Invisicare®.
Skinvisible’s primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products.
CLICK HERE TO SEE CURRENT LICENSEES.
The Technology: Invisicare® is a patented technology that enhances how drugs are delivered on, in or through the skin. It can control the release of active ingredients, providing a greater and longer release, while at the same time reducing irritation to the skin. It also binds products to the skin for 4 hours and more, resisting wash-off and rub-off. Skinvisible has developed a portfolio of 40+ topical products using Invisicare (prescription, over-the-counter and cosmeceutical) and also works directly with companies to enhance their products, especially ones coming off patent. Invisicare can be tailored to almost any type of molecule and the needs our customers. Learn more at WWW.INVISICARE.COM.
News
September 15, 2016
SKINVISIBLE SIGNS GLOBAL LICENSING AGREEMENT FOR ITS CANNABIS PRODUCTS – Invisicare Enhances The Delivery Of Topical Medical Marijuana In New Product Line
September 8, 2016
SKINVISIBLE SUBSIDIARY SIGNS DISTRIBUTION AGREEMENT FOR GREATER CHINA – Kintari Branded Skin Care Products To Entering The Asian Marketplace
TERRY HOWLETT
Skinvisble President & Chief Executive Officer
Mr. Howlett founded Skinvisible, Inc. in 1998. With over 30 years of entrepreneurial, business management and market initialization experience, he drives and directs the Company’s development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation, strategic planning and business growth; specializing in venture capital financing. Mr. Howlett’s diversified background includes senior management, marketing, and sales positions with both established and start-up companies.
Pressure Biosciences, Inc.
(Stock Symbol: PBIO)
Lab Instruments Medical Products Stock
Pressure BioSciences, Inc. (OTCQB: PBIO) is a life sciences tools company focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on our game-changing Pressure Cycling Technology (“PCT”).
PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels (up to 90,000 psi) to safely, conveniently and reproducibly control the actions of molecules in biological samples, e.g., the rupture (lysis) of cells and tissues from human, animal, plant, and microbial sources, and the inactivation of pathogens.
See Pressure BioSciences Life Sciences Lab Instruments Products Page
Pressure BioSciences, Inc. (“PBI”) (PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions.
To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. Customers also use our products in other areas, such as bio-therapeutics characterization, soil & plant biology, vaccine development, and counter-bioterror applications.
March 14, 2017
Where To Invest Undervalued Stocks
Undervalued Medical Products Stock
On Money Info Investment News Show
The March 14, 2017 show features a live interview with
Andy Sealfon, CEO & Chairman of RMS Medical Systems, Inc.
(Stock Symbol: REPR)
Listen to a Replay of the Interview:
Listen to a Replay of Part 1 of the show:
Visit the corporate website: RMSMedicalProducts.com
Click Here For REPR stock quotes,
trading charts and latest news releases
See RMS Medical Investors Information Page with financials
RMS Medical Products – inspiration for health, freedom for living
RMS Medical Products MISSION:
To improve the Quality of Life of patients around the world
through the design, development and delivery of the
highest quality innovative therapeutic solutions.
Worldwide, RMS Medical Products drives healthcare inspiration – in the minds of our patients, our employees, our customers and our shareholders – to give everyone greater freedom for living. We design and manufacture safe, affordable medical devices to make quality healthcare a reality for everyone.
We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers, and careful consideration for the patient experience. Our primary products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™ and RES-Q-VAC®Hand Held Medical Suction.
We are passionate about helping people with our reliable medical devices made at our HQ in Chester, NY (USA). Our products, as well as product support, are offered worldwide by RMS and through a global network of distributors and service providers.
President, Chairman of the Board of Directors, Co-Founder
Andrew Sealfon, President of the company and Chairman of the Board of Directors, co-founded the company in 1980. Mr. Sealfon is an electrical engineer and inventor and has been granted numerous United States patents. He previously was a member of the Technical Staff of ITT Federal Laboratories, and a member of the research staff of Riverside Research Institute. Mr. Sealfon is a graduate of Lafayette College and continued his graduate studies at Polytechnic Institute of Brooklyn.
The Freedom60 has a proprietary technology
that makes it desirable for the
delivery of medications in a wide variety of therapies.
It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.
Medical Stock News
RMS announces hiring of Eric Bauer as Chief Operating Officer
Mr. Bauer brings to RMS over 25 years of experience driving operational excellence in growing organizations within FDA regulated environments. – See News
Undervlaued Medical Products Stocks
Where To Invest Undervalued Stocks
March 7, 2017
Medical Equipment Stock News, Undervalued Medical Stocks
on Investment News Show
The show March 7th features an interview with
Ric Schumacher, President of
Pressure Biosciences, Inc.
(Stock Symbol: PBIO)
Lab Instruments Medical Products Stock
Listen to a replay of the Interview:
The Show Also Features
Texas Oil and Gas investing News
Live Interview with Tim Connolly of Texas Gulf Oil
Tim discusses undervalued oil & gas stocks and where to invest now in the oil & gas sector.
Hear Part 1 of the show, with oil and gas investing news from Tim Connolly:
See corporate site: PressureBiosciences.com
Get PBIO Stock Quote
See Latest Company Press Releases
Pressure BioSciences, Inc. (OTCQB: PBIO) is a life sciences tools company focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on our game-changing Pressure Cycling Technology (“PCT”).
PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels (up to 90,000 psi) to safely, conveniently and reproducibly control the actions of molecules in biological samples, e.g., the rupture (lysis) of cells and tissues from human, animal, plant, and microbial sources, and the inactivation of pathogens.
See Pressure BioSciences Life Sciences Lab Instruments Products Page
Pressure BioSciences, Inc. (“PBI”) (PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions.
To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. Customers also use our products in other areas, such as bio-therapeutics characterization, soil & plant biology, vaccine development, and counter-bioterror applications.
Small Cap Stocks To Buy
Investment News Show Replays
Money Info Show
Replay Archives
Hear Replays of February 2017 to December 2016 Shows:
Hear Replays of
December 2016 to July 2016 Shows
Hear Replays of
June 2016 to April 2016 Shows
Hear Replays of
March 2016 to January 2016 Shows
Hear Replays of
December 2015 to October 2015 Shows
Hear Replays of
December 2015 to October 2015 Shows
Click Here
Hear Replays of
September 2015 to June 2015 Shows
Click Here
Hear Replays of
June 2015 to April 2015 Shows
Click Here
The Princeton Research Money Info Show features
where to invest now,
stock market, business, economy and
financial investment news.
Stock Options Trading Alerts Update:
In order to make more investors aware of the exceptional gains we are producing with our Options Trading Alerts Service we are offering (for a very limited time) free sample trade alerts and sample issues of the Market Strategies Newsletter.
See http://www.princetonresearch.com/options-trading.htm to get in today.